Loading chat...

CT SB00025

Bill

Status

Introduced

1/9/2017

Primary Sponsor

Insurance and Real Estate Committee

Click for details

Origin

Senate

2017 General Assembly

AI Summary

  • Requires health carriers to issue immediate electronic authorization to pharmacies to dispense a temporary supply of prescribed drugs (excluding Schedule II and III controlled substances) when a covered person files a grievance or requests review of an adverse determination.

  • The temporary drug supply must be sufficient for the duration of the grievance or review process, with confirmation that payment will be available.

  • Health carriers must confirm with the prescribing provider within 24 hours of issuing authorization that the provider concurs with dispensing the temporary supply; if the provider does not concur, the carrier must cancel the authorization.

  • Exceptions apply to grievances or reviews concerning substitution of generic drugs or alternative brand name drugs for prescribed brand name drugs, unless the prescriber specified no substitution.

  • All provisions take effect January 1, 2018, and apply to adverse determination reviews under sections 38a-591d, 38a-591e, 38a-591f, and 38a-591g of Connecticut General Statutes.

Legislative Description

An Act Requiring Health Insurance Coverage Of A Prescribed Drug During Adverse Determination Reviews And External Review Processes.

Last Action

Referred to Joint Committee on Insurance and Real Estate

3/3/2017

Committee Referrals

Insurance and Real Estate1/9/2017

Full Bill Text

No bill text available